A Clinical Trial Derived Reference Set for Evaluating Observational Study Methods
暂无分享,去创建一个
Nigam H. Shah | Steve Yadlowsky | Ethan Steinberg | N. Shah | S. Yadlowsky | E. Steinberg | Steve Yadlowsky
[1] Peter C. Austin,et al. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis , 2016, Statistics in medicine.
[2] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[3] Wei Ma,et al. RxNorm: prescription for electronic drug information exchange , 2005, IT Professional.
[5] M Soledad Cepeda,et al. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. , 2003, American journal of epidemiology.
[6] Paige L. Williams,et al. Challenges in using observational studies to evaluate adverse effects of treatment. , 2007, The New England journal of medicine.
[7] Alison Callahan,et al. It is time to learn from patients like mine , 2019, npj Digital Medicine.
[8] M. Schuemie,et al. Defining a Reference Set to Support Methodological Research in Drug Safety , 2013, Drug Safety.
[9] D. Rubin,et al. The central role of the propensity score in observational studies for causal effects , 1983 .
[10] George Hripcsak,et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis , 2019, The Lancet.
[11] D. Matchar,et al. Making Clinical Practice Guidelines Pragmatic: How Big Data and Real World Evidence Can Close the Gap. , 2018, Annals of the Academy of Medicine, Singapore.
[12] Louise Bowman,et al. The Magic of Randomization versus the Myth of Real-World Evidence. , 2020, The New England journal of medicine.
[13] Amy P. Abernethy,et al. Harnessing the Power of Real‐World Evidence (RWE): A Checklist to Ensure Regulatory‐Grade Data Quality , 2017, Clinical pharmacology and therapeutics.
[14] Nigam H. Shah,et al. Language Models Are An Effective Patient Representation Learning Technique For Electronic Health Record Data , 2020, ArXiv.
[15] D. Moher,et al. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.
[16] Richard K. Crump,et al. Moving the Goalposts: Addressing Limited Overlap in Estimation of Average Treatment Effects by Changing the Estimand , 2006, SSRN Electronic Journal.
[17] Adrian Towse,et al. Real-world evidence for coverage decisions: opportunities and challenges. , 2018, Journal of comparative effectiveness research.
[18] Issa J Dahabreh,et al. Can the learning health care system be educated with observational data? , 2014, JAMA.
[19] David Madigan,et al. Good practices for real‐world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR‐ISPE Special Task Force on real‐world evidence in health care decision making , 2017, Pharmacoepidemiology and drug safety.
[20] A. Krauss. Why all randomised controlled trials produce biased results , 2018, Annals of medicine.
[21] Martijn J. Schuemie,et al. Replication of the OMOP Experiment in Europe: Evaluating Methods for Risk Identification in Electronic Health Record Databases , 2013, Drug Safety.
[22] Martijn J. Schuemie,et al. A Reference Standard for Evaluation of Methods for Drug Safety Signal Detection Using Electronic Healthcare Record Databases , 2012, Drug Safety.
[23] Alison Callahan,et al. Performing an Informatics Consult: Methods and Challenges. , 2018, Journal of the American College of Radiology : JACR.
[24] Olivier Bodenreider,et al. The Unified Medical Language System (UMLS): integrating biomedical terminology , 2004, Nucleic Acids Res..
[25] G. Nicholas,et al. Are clinical trial eligibility criteria an accurate reflection of a real-world population of advanced non-small-cell lung cancer patients? , 2018, Current oncology.
[26] James M. Robins,et al. Marginal Structural Models versus Structural nested Models as Tools for Causal inference , 2000 .
[27] A. Nowacki,et al. Understanding Equivalence and Noninferiority Testing , 2011, Journal of General Internal Medicine.
[28] M. Fay. Confidence intervals that match Fisher's exact or Blaker's exact tests. , 2010, Biostatistics.
[29] Charles E. Leonard,et al. Comment on: “Desideratum for Evidence-Based Epidemiology” , 2014, Drug Safety.
[30] S. Bacon,et al. Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study , 2020, The Lancet.
[31] George Hripcsak,et al. How Confident Are We about Observational Findings in Healthcare: A Benchmark Study. , 2020, Harvard data science review.
[32] O. Baser. Choosing propensity score matching over regression adjustment for causal inference: when, why and how it makes sense , 2007 .